***********MARKET RESEARCH ONLY***********

Please see the attached Sources Sought for Nucleic Acid Testing (NAT), with capability for Hepatitis C (HCV), Hepatitis B Virus (HBV), Human Immunodeficiency Virus (HIV), and West Nile Virus (WNV) testing. This is a sources sought synopsis only, (not a pre-solicitation notice pursuant to FAR Part 5). The purpose of this notice is to gain knowledge of potential qualified sources.

Responses to this notice shall include the following: a) Company Name, b) Address, c) Cage Code, d) DUNS Number, e) Point of Contact, and f) any specific socioeconomic small business category (i.e. 8(a), HUBZONE, Women-Owned, Service-Disabled Veteran-Owned, etc.).

In addition, the respondent must provide a Capability Statement that addresses the organization's qualifications and ability to support and perform as a prime contractor the work described below:

The contractor shall provide Nucleic Acid Testing (NAT), with capability for Hepatitis C (HCV), Hepatitis B Virus (HBV), Human Immunodeficiency Virus (HIV), and West Nile Virus (WNV) testing.

The Armed Services Blood Bank Center-San Antonio (ASBBC-SA), JBSA-Lackland, TX, requires the capability to perform NAT, with capability for HCV, HBV, HIV, and WNV, for the ASBBC-SA, JBSA-Lackland, TX. The system must be fully automated, integrated Nucleic Acid Testing platform, for blood screening, enabling ASBBC-SA to process up to 500 samples per shift for Ultrio and WNV and maintain a critical turnaround time of 10 hours or less from time of receipt, given extensive laboratory volume. The term fully automated means that no human interaction is required while the instrument processes the sample.

The system must also possess the added capability of screening (compounded result) to discriminatory test (individual result using discriminatory probe assays), all on the same platform.

Platform must fit in 12 x 15 foot space, and utilize existing power available in the designated laboratory space.